Uncontrolled acromegaly is associated with progressive mitral valvular regurgitation

被引:37
作者
van der Klaauw, AA
Bax, JJ
Roelfsema, F
Bleeker, GB
Holman, ER
Corssmit, EPM
van der Wall, EE
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands
关键词
acromegaly; valvular regurgitation; follow-up;
D O I
10.1016/j.ghir.2006.02.002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Introduction: Recent cross-sectional studies have documented an association between acromegaly and regurgitant valvular heart disease. The aim of this study was to evaluate the change in prevalence of valvular heart disease in relation to the clinical activity, because the natural history of valvular changes in acromegaly is unknown. Patients and methods: Valvular regurgitation was assessed in 37 acromegalic patients (18 patients with active disease, and 19 with controlled disease) by conventional two-dimensional and Doppler echocardiography before and after an interval of 1.9 years (range 1.5-3.0 years). Results: At baseline, valvular regurgitation (mitral and aortic sites combined) was present in 46% of the patients and increased to 67% at follow-up (P = 0.008). Mitral regurgitation increased significantly from 32% to 60% (P = 0.002), but no change was noted for the aortic valve (27% vs. 31%, NS). In patients with active disease, valvular regurgitation increased significantly from 56% at baseline to 88% at follow-up (P = 0.031) due to a significant increase of mitral regurgitation from 39% to 78% at follow-up (P = 0.016). In contrast, no increase in valvular regurgitation was found in patients with controlled disease. Conclusion: The prevalence of mitral, but not aortic, valvular regurgitation increased in patients with active acromegaly during follow-up. Patients with acromegaly require adequate cardiac evaluation and follow-up to establish the extent and progression of valvular involvement. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 21 条
[1]   Cardiovascular function in acromegaly [J].
Clayton, RN .
ENDOCRINE REVIEWS, 2003, 24 (03) :272-277
[2]   Cardiovascular effects of depot long-acting somatostatin analog sandostatin LAR in acromegaly [J].
Colao, A ;
Marzullo, P ;
Ferone, D ;
Spinelli, L ;
Cuocolo, A ;
Bonaduce, D ;
Salvatore, M ;
Boerlin, V ;
Lancranjan, I ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3132-3140
[3]   Systemic complications of acromegaly: Epidemiology, pathogenesis, and management [J].
Colao, A ;
Ferone, D ;
Marzullo, P ;
Lombardi, G .
ENDOCRINE REVIEWS, 2004, 25 (01) :102-152
[4]   High prevalence of cardiac valve disease in acromegaly: An observational, analytical, case-control study [J].
Colao, A ;
Spinelli, L ;
Marzullo, P ;
Pivonello, R ;
Petretta, M ;
Di Somma, C ;
Vitale, G ;
Bonaduce, D ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3196-3201
[5]   Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance [J].
Colao, A ;
Cuocolo, A ;
Marzullo, P ;
Nicolai, E ;
Ferone, D ;
Morte, AMD ;
Pivonello, R ;
Salvatore, M ;
Lombardi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (04) :1551-1557
[6]   ECHOCARDIOGRAPHIC ASSESSMENT OF LEFT-VENTRICULAR HYPERTROPHY - COMPARISON TO NECROPSY FINDINGS [J].
DEVEREUX, RB ;
ALONSO, DR ;
LUTAS, EM ;
GOTTLIEB, GJ ;
CAMPO, E ;
SACHS, I ;
REICHEK, N .
AMERICAN JOURNAL OF CARDIOLOGY, 1986, 57 (06) :450-458
[7]   Quantitative determinants of the outcome of asymptomatic mitral regurgitation [J].
Enriquez-Sarano, M ;
Avierinos, JF ;
Messika-Zeitoun, D ;
Detaint, D ;
Capps, M ;
Nkomo, V ;
Scott, C ;
Schaff, HV ;
Tajik, AJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (09) :875-883
[8]  
Feelders RA, 2002, 84 ANN M END SOC SAN, P76
[9]   Reference values for echocardiographic measurements in urban and rural populations of differing ethnicity: The Strong Heart Study [J].
Ilercil, A ;
O'Grady, MJ ;
Roman, MJ ;
Paranicas, M ;
Lee, ET ;
Welty, TK ;
Fabsitz, RR ;
Howard, BV ;
Devereux, RB .
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2001, 14 (06) :601-611
[10]   Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics [J].
Minniti, G ;
Jaffrain-Rea, ML ;
Moroni, C ;
Baldelli, R ;
Ferretti, E ;
Cassone, R ;
Gulino, A ;
Tamburrano, G .
CLINICAL ENDOCRINOLOGY, 1998, 49 (01) :101-106